The results of PAS staining and EM revealed that anti-ANGPTL3/IL22 fusion protein improved glomerular mesangial matrix hyperplasia, morphology of intra-glomerular capillary collaterals and foot process effacement, showing the strongest protective effect against DN in all groups. Here, IL22 is linked to liver dysplastic nodule.